| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |